Roopa Industries Ltd (ROOPAIND) — shareholding pattern, promoter holding, financials and share price
About Roopa Industries Ltd (ROOPAIND)
Roopa Industries Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as ROOPAIND and on the BSE under scrip code 530991. Its ISIN is INE443C01010.
Incorporated in 1985, Roopa Industries Ltd is in the business of TPP and its allied products [1]
Roopa Industries Limited, part of the TGV Group, is a manufacturer and exporter of Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids, and Water Treatment Chemicals, with operations since 1985.
The company transitioned into producing Neutraceuticals, Fine chemicals, Drug Intermediates, and Bulk Drugs in 1998, serving a wide range of international clients.
Listed peers in Pharmaceuticals: Sandu Pharmaceuticals Ltd, Lasa Supergenerics Ltd, JFL Life Sciences Ltd, Parmax Pharma Ltd, Medi Caps Ltd.
Valuation & Returns
10 Jul 2026At ₹46.57 a share on 10 Jul 2026, Roopa Industries Ltd (ROOPAIND) was valued at a price-to-earnings ratio of 457.87x against an industry P/E of 36.41x and a price-to-book of 2.09x on a book value of ₹22.24 per share as of Mar 2025. Solomo computes return on equity of 0.46% and return on capital employed of 6.7% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 457.87x
- Industry P/E
- 36.41x
- P/B
- 2.09x
- EPS (TTM)
- ₹0.1
- Book value / share
- ₹22.24
- ROE
- 0.46%
- ROCE
- 6.7%
- ROA
- 0.1%
- Debt / equity
- 1.9x
- Dividend yield
- 0%
- EBITDA margin
- 3.29%
- 52-week range
- ₹45.14 – ₹49
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Roopa Industries Ltd (ROOPAIND) reported revenue of ₹128 crore and earnings per share of ₹0.1. That compares with revenue of ₹121 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹30.14 crore and net profit ₹-1.43 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 51 | 76 | 70 | 121 | 128 |
| Net profit (₹ cr) | 1 | 1 | 2 | 2 | 0 |
| EPS (₹) | 1.3 | 1.72 | 1.93 | 2.58 | 0.1 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 15.38% | 34.28% | 33.08% | 71.36% |
| Profit growth | 31.64% | 40.47% | 26.09% | 33.55% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 48.03% of Roopa Industries Ltd (ROOPAIND) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.25%. Market capitalisation was ₹37 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: SANGEETHA S 9.51%, MAHENDRA GIRDHARILAL 2.15%, B HULTHENNA 1.5%, USHA NATH 1.37%, P P ZIBI JOSE 1.3%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 48.03% | - | 0.25% | - | 51.97% |
| Mar 2026 | 48.03% | - | 0.25% | - | 51.97% |
| Dec 2025 | 48.03% | - | 0.25% | - | 51.97% |
| Sep 2025 | 48.03% | - | 0.25% | 0% | 51.97% |
| Jun 2025 | 48.03% | - | 0.25% | - | 51.97% |
| Mar 2025 | 48.03% | - | 0.25% | - | 51.97% |
| Dec 2024 | 48.03% | - | 0.25% | - | 51.97% |
| Sep 2024 | 48.03% | - | 0.25% | - | 51.97% |